The party’s annual policy retreat comes amid challenges posed by the Middle East war and weakening economy.

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Compass Pathways has successfully met its primary goals in its late-stage clinical trials, demonstrating that its lead therapy delivers significant patient benefits. The latest results confirm that ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

SHERIDAN, WY - March 10, 2026 - PRESSADVANTAGE - Furnirem, the family-led handcrafted solid wood furniture brand based ...

Acinetobacter baumannii is a bacteria which can become a virulent killer in health-care settings among severely ill patients. The germ has rapidly developed drug resistance to even last-line ...

This week’s Executive Dysfunction.

Live Steve Sommers Overnight Drive broadcasts, specials, giveaways, and Jeff Hirt’s modified pulling tractor highlight ...

The National Education Opportunity Network (NEON), a nonprofit committed to propelling economic mobility for talented scholars nationwide, today announced the newest inductees into its National Honor ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Canada needs to ...

According to data from a new peer-reviewed, real-world study, the "standard" Semen Analysis test can come back "normal" ...

Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.